Concurrent 5-fluorouracil, daily low-dose cisplatin, and radiotherapy in stage IIIB cervical cancer: A phase II prospective study

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 19, Issue 3, 1996, Pages 263-267

  Hsu, Wen Lin ^a   Shueng, Pei Wei ^a   Jen, Yee Min ^a   Wu, Ching Jung ^a   Liu, Hang Seng ^a   Su, Chih Chung ^a   Hwang, Jing Min ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Cervical cancer; Daily low dose cisplatin; Synchronous combination treatment

Indexed keywords

CESIUM 137; CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HYSTERECTOMY; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; METASTASIS; PHASE 2 CLINICAL TRIAL; RADIATION DOSE; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; UTERINE CERVICAL NEOPLASMS;

EID: 0029973091     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199606000-00011     Document Type: Article

References (31)

1. Ludgate SM, Crandon AJ, Hudson CN, et al. Synchronous 5-FU, mitomycin-C and radiation therapy in the treatment of locally advanced carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1988;15:893-9.
2. Pettersson F, Bjorkholm E. Staging and reporting of cervical cancer. Semin Oncol 1982;9:287-98.
3. Lanciano RM, Martz K, Coia LR, et al. Tumor and treatment factors improving outcome in stage IIIB cervix cancer. Int J Radial Oncol Biol Phys 1991;20:95-100.
4. Medical Research Council. Report of MRC Working Party on the use of misonidazole in the treatment of carcinoma of the cervix. Br J Radiol 1984;57:491-9.
5. Dische S. Hyperbaric oxygen: the Medical Research Council trials and their clinical significance. Br J Radiol 1978;51:888-94.
6. Watson ER, Halnan KE, Constable W. Hyperbaric oxygen and radiotherapy: a Medical Research Council trial in carcinoma of the cervix. Br J Radiol 1978;51:879-87.
7. Nigro ND, Vaitkevicius VK, Creasman WT, et al. Chemotherapy of gynecologic cancer with nitrosoureas: a randomized trial of CCNU and methyl-CCNU in cancers of cervix, corpus, vagina and vulva. Cancer Treat Reports 1978;2:833-9.
8. Byfield JE, Barone R, Mendelsohn J, et al. Infusional 5-Fluorouracil and X-ray therapy for non-resectable esophageal cancer. Cancer 1980;45:703-8.
9. Franklin R, Steiger Z, Vaihampayan G, et al. Combined modality therapy for esophageal squamous cell carcinoma. Cancer 1983;53:1062-97.
10. Byfield JE, Stanton W, Sharp TR, et al. Phase I-II study of 120 hour infused 5-FU and split course radiation therapy in localized non-small cell lung cancer. Cancer Treat Reports 1983;67: 933-6.
11. Cohen JT, Krant KJ, Snider BF, et al. Radiation plus 5-fluorouracil (NSC-19893): clinical demonstration of an effect in bronchogenic carcinoma. Cancer Chemother Reports 1971;55: 253-8.
12. Carter S. The chemotherapy of head and neck cancer. Semin Oncol 1977;4:413-24.
13. Rogers KM, Mckay CE, Magee MJ, et al. Continuous infusion 5FU and cisplatin for advanced squamous cell carcinoma of the cervix [Abstract 613]. Proc Am Soc Clin Oncol 1989;8:157.
14. Kim NK, Bang YJ, Kang YK. A phase II trial of 5-fluorouracil (5-FU) infusion and cisplatin (FP) for advanced squamous cell carcinoma of the uterine cervix (SCCUC) [Abstract 647]. Proc Am Soc Clin Oncol 1989;8:16.
15. Rotmensch J, Senekjian EK, Kavaheri G, et al. Evaluation of bolus cis-platinum and continuous 5-fluorouracil infusion for metastatic and recurrent squamous cell carcinoma of the cervix. Gynecol Oncol 1988;29:76-81.
16. Gynecologic Oncology Group. The GOG adverse effects criteria. In: DiSaia PJ, Creasman WT. Clinical gynecologic oncology. 3rd ed. St Louis: C.V. Mosby, 1989:674-80.
17. Rubin P. Law and order of radiation sensitivity. In: Vaeth JM, Meyer JL. Radiation tolerance of normal tissues. Basel: Karger, 1989:7-40.
18. Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assn 1958;53:457-81.
19. John M, Flam M, Sikic B, et al. Preliminary results of concurrent radiotherapy and chemotherapy in advanced cervical carcinoma: a phase I-II prospective intergroup NCOG-RTOG study. Gynecol Oncol 1990;37:1-5.
20. Chang HC, Lai C-H, Chen MS, et al. Preliminary results of concurrent radiotherapy and chemotherapy with cis-platinum, vincristin and bleomycin in bulky, advanced cervical carcinoma: a pilot study. Gynecol Oncol 1992;44:182-8.
21. Heaton D, Yoedan E, Beddy S, et al. Treatment of 29 patients with bulky squamous cell carcinoma of the cervix with simultaneous cisplatin, 5-fluorouracil, and split-course hyperfractionated radiation therapy. Gynecol Oncol 1990;38:323-7.
22. John M, Cooke JK, Flam M, et al. Preliminary results of concomitant radiotherapy and chemotherapy in advanced cervical carcinoma. Gynecol Oncol 1987;28:101-10.
23. Kuske H-B, Perez CA, Grigsby PW, et al. Phase I/II study of definitive radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) for advanced or recurrent gynecologic malignancies, preliminary report. Am J Clin Oncol 1989;12:467-73.
24. Malviya VK, Deppe G, Kim Y, et al. Concurrent radiation therapy, cis-platinum, and mitomycin c in patients with poor prognosis cancer of the cervix: a pilot study. Am J Clin Oncol 1989;12: 434-7.
25. Robert WS, Kavanagh JJ, Greenberg H, et al. Concomitant radiation therapy and chemotherapy in the treatment of advanced squamous carcinoma of the lower female genital tract. Gynecol Oncol 1989;34:183-6.
26. Thomas G, Dembo A, Beale F, et al. Concurrent radiation, mitomycin C and 5-fluorourcil in poor prognosis carcinoma of the cervix. Preliminary results of a Phase I-II study. Int J Radiat Oncol Biol Phys 1984;10:1785-90.
27. Wu CJ, Hsu WL, Su CC, Jen YM, Yen SH. Radiation therapy for cervical cancer: analysis of treatment failure [Abstract]. In: Proceedings of the Seventy-Eighth Annual Meeting of the Radiological Society of North America 1992;286:150.
28. Albert DS, Garcia D, Mason-Liddil N. Cisplatin in advanced cancer of the cervix: an update. Semin Oncol 1991;18(suppl 3): 11-24.
29. Boven E, Stam TJ, Pinedo HM. Combined radiation therapy and daily low-dose cisplatin for inoperable, locally advanced non-small cell lung cancer: results of a phase II trial. Semin Oncol 1988;15(Suppl 7):18-19.
30. Schaake-Koning C, Maat B, Houtte PV, et al. Radiotherapy combined with low-dose cis-diammine dichloroplatinum(II)(CDDP) in inoperable nonmetastatic non-small cell lung cancer (NSCLC): a randomized three arm phase II study of the EORTC lung cancer and radiotherapy cooperative groups. Int J Radiat Oncol Biol Phys 1990;19:967-72.
31. Ellerbroek NA, Fossella FV, Rich TA, et al. Low-dose continuous infusion cisplatin combined with external beam irradiation for advanced colorectal adenocarcinoma and unresectable non-small cell lung carcinoma. Int J Radiat Oncol Biol Phys 1991;20: 351-5.